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Dynamic redefinition of the 10 UGAs in human and mouse selenoprotein P
(Sepp1) mRNAs to specify selenocysteine instead of termination involves two
30 UTR structural elements (SECIS) and is regulated by selenium availability.
In addition to the previously known human Sepp1 mRNA poly(A) addition
site just 30 of SECIS 2, two further sites were identified with one resulting in
10–25% of the mRNA lacking SECIS 2. To address function, mutant mice
were generated with either SECIS 1 or SECIS 2 deleted or with the first UGA
substituted with a serine codon. They were fed on either high or selenium-
deficient diets. The mutants had very different effects on the proportions of
shorter and longer product Sepp1 protein isoforms isolated from plasma,
and on viability. Spatially and functionally distinctive effects of the two
SECIS elements on UGA decoding were inferred. We also bioinformatically
identify two selenoprotein S mRNAs with different 50 sequences predicted
to yield products with different N-termini. These results provide insights into
SECIS function and mRNA processing in selenoprotein isoform diversity.
1. Introduction
The genetic code is not fixed as once thought but evolving, and its readout is also
dynamic. Selenocysteine, Sec, specification illustrates both aspects. It is specified
byUGU inAeromonas salmonicida, UAG in Blastococcus andUGA in Escherichia coli
and eukaryotes [1]. In the great majority of vertebrate mRNAs, UGA specifies
termination and how its meaning is dynamically redefined to specify seleno-
cysteine in a very small number of coding sequences, 25 in humans, is of great
interest. While nearly all selenoprotein encoding eukaryotic mRNAs have a
single UGA-specifying selenocysteine, mammalian selenoprotein P (Sepp1)
mRNAs have multiple such UGAs, 10 in rat and human [2,3]. The efficiency
required for independent reprogramming of the ribosome at each of suchmultiple
UGAs raises the possibility of the ribosome involved becoming specialized for
processive decoding of at least the more 30 UGAs to specify selenocysteine [4,5].
& 2016 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.
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Even in relation to certain othermRNAs, the concept of discrete
classes of ribosomes has been gaining ground [6,7].
A crucial component of eukaryotic selenocysteine specifica-
tion is part of the 30 UTR forming a structure termed SECIS
[8,9]. There is just one in each selenoprotein mRNA [9],
except for Sepp1 mRNAwhich has two [2]. Eukaryotic SECIS
elements are kink turn structures featuring a quartet of non-
Watson Crick pairing with a central tandem of sheared G.A
pairs [10] and are of two types [11,12]. The Sepp1 SECIS 2,
which is closest to the 30 end, is a form one element that lacks
an additional secondary structure element in SECIS 1, a form
two element. Prior work, under conditions less close to
the native situation than investigated in the present work, led
to the concept that SECIS 2 is primarily involved in recod-
ing UGA 1, and SECIS 1 mediates its effect on the more
30 UGAs [13–15].
At least two proteins derived from the single selenoprotein
P gene in mammals are present in plasma. The full-length pro-
duct (P signifies plasma) [16,17] accounts for approximately
80% of plasma selenium [18,19]. The N-terminal domain,
two-thirds of the 361 amino acid sequence (figure 1a), with
its sole selenocysteine, contains a thioredoxin-like redox
motif (residues 40–43) in which selenocysteine replaces one
of the cysteine residues (figure 1a). Mass spectrometric analysis
revealed that 11 shorter forms, urinary Sepp1 (Sepp1UF), have
the same N-termini but their C-termini are various residues
between 183 and 208 [32]. When it is ultimately filtered into
urine, it is recovered by PCT cells via megalin-mediated endo-
cytosis, preventing loss of selenium [32,33]. The redox motif
has peroxidase activity when reduced by NADPH through
thioredoxin reductase-1 [32]. The N-terminal domain is rel-
evant to protection against oxidative stress, and evidence for
other protective effects comes from studies on infection by
Trypanosoma congolense [34]. Sepp1 has a heparin binding site,
(residues 79–86) whose activity is dependent on acidic
conditions, which, for instance, occur in inflammation.
It is unclear whether there are other functionally important
Sepp1 mRNA-derived protein isoforms. The 30 one-third of the
coding sequence contains nine selenocysteine-specifying UGA
codons. Products due to termination at a specific subset have
been detected; in rat these are at UGA 2, 3 and 7 [35]. (This
study involved 75Se labelling and so would not have detected
termination at UGA 1.) It is unknown whether or not these
derive from inefficiency in establishing the fully specialized
state for selenocysteine specification and are without functional
consequence. Transient transfection and in vitro protein
synthesis studies have also shown that efficiency of seleno-
cysteine specification at the 50 UGAs, especially the first one, is
less than can simply be obtained by substituting SECIS 2 with
SECIS 1 [13–15]. Given the complexity of the processes
involved, caution emanating fromstudies of the ionic conditions
and other features of tRNA (Sec) binding to membranes [36],
and the potential for events associated with expression from
the endogenous gene location being relevant, we altered rel-
evant features of the native gene in mouse, and studied the
consequences at the level of product present in plasma, and
phenotype evident under either selenium replete or selenium-
deficient diets. Relevantly, the efficiency of selenocysteine
specification for a subset of selenoprotein mRNAs varies with
stress levels and in several instances is influenced by selenium
levels [35,37–40]. Though not studied here, it is also pertinent
that under low selenium conditions UGAs in Sepp1 mRNA
undertake some level of cysteine specification [41].
The glycosylation of Sepp1 has been a complication in the
analyses to date. In the rat, approximately 9000 Da of carbo-
hydrate is present as three N-glycosylations in the N-terminal
domain and, in some molecules, one O-glycosylation in the
C-terminal domain [35]. Details of mouse Sepp1 glycosylation
have not been reported.
In contrast to the evidence indicating occurrence and poss-
ible importance of some level of termination at least at some of
the 50-most UGAs, high efficiency of selenocysteine speci-
fication by UGAs further 30 is evident, and when 28 UGAs
occur, as in sea urchin [42], would seem to be required for syn-
thesis of full-length product. Presumably C-terminal extension
[42] was driven by the need, especially in low selenium con-
ditions, for some tissues to have higher selenium levels than
provided by an uncharacterized small molecule form(s) that
lacks specificity [43,44]. Studies with controlled inactivation
of mouse Sepp1 expression showed that 5–10% is expressed
in non-liver tissues. However, the liver accounts for app-
roximately 90% of plasma SEPP1 and is responsible for
supplying extra-hepatic tissues with selenium through this
transport mechanism [45,46]. Brain and testis [47,48] as well
as bone [49], are among the important destinations. With
recombinant Sepp1 lacking selenocysteine, it was shown that
residues 324–326 in the selenium-rich C-terminal domain are
necessary for its binding to apolipoprotein E receptor-2
(apoER2). This site is indicated with dashed lines in figure 1a.
apoER2 binding mediates endocytosis of Sepp1, providing
cells expressing this receptor with selenium for synthesis of
their selenoproteins [50]. In this study, ‘long form’ refers to pro-
teins that contain the apoER2 binding site and so can be taken
up by cells. They extend beyond residue 326. We refer to ‘short
forms’ as those that do not extend to amino acid 326 and do not
transport selenium to tissues with the main exception of the
kidney (figure 1b). More precise designation was hampered
by the number of forms. Any ultra-short forms arising from ter-
mination at the first UGA, or before it, would not have been
detected in this study as they would not contain selenium
andwould not contain the binding site for themonoclonal anti-
body, 9S4, used in these studies (the location of the binding site
in the N-terminal region is unknown).
There is increasing realization of the importance of tran-
script variants in tunable protein synthesis [51]. This study
also deals with mRNA variants derived from the single
Sepp1 gene present in humans and in mice. The mouse
mRNA variants characterized to date differ in their 50 non-
coding exons, exons 1a, 1b and 1c, but have the same
coding sequence (exons 2–5) [20]. All known human variants
begin with the same non-coding exon, but two of the three
variants have an additional exon inserted after the first
exon. Suggestive of a regulatory role for the mouse variants
is developmental stage changes in their distribution in heart
and kidney, and localization of the 1b variant specifically to
the hippocampus where its 50 end is a target of the micro
RNA Mir7 [20].
While no Sepp1 mRNAvariants with different 30 UTRs are
known, such an mRNA variant is known for human seleno-
protein S [21]. Selenoprotein S participates in intracellular
membrane transport and consistent with being involved in
removing misfolded proteins from the endoplasmic reticulum
(ER), its synthesis is upregulated in conditions of ER stress
[22,23]. Alternative splicing of selenoprotein S mRNA 8 nt
from the start of the 30 UTR yields a minority of transcripts
that lack the sole SECIS element. Translation of these
rsob.royalsocietypublishing.org
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transcripts results in the penultimate codon, the sole UGA,
mediating termination instead of selenocysteine specification
[21]. The efficiency of selenocysteine specification and likely
splicing are influenced by an mRNA structural element,
known as SRE, 30 adjacent to theUGA that in SECIS-containing
transcripts specifies selenocysteine [21]. SRE elements are stem-
loop structures adjacent to a subset of eukaryotic selenoprotein
mRNAs that play a role in selenocysteine specification [52–55].
1
N-terminal
40
1
ultra-short form
40
1
short form
1
long form
40 240 323
324
SECIS
1 2
361
An
CDS
400
350
300
250
200
150
100
50
0
0 1 2 5 10
sodium selenite concentration (nM)
fo
ld
 c
ha
ng
e 
m
RN
A
 re
la
tiv
e 
to
 0
 n
M
20 50 100
A1
A2
B1
B2
C1
canonical form
variants
UTR
An
B1;
B2
A1;
A2C1
apoER2
site
44 79 86 183 208
proteolytic
cleavage
sites
heparin
binding
site
(a)
(b)
(c)
(d)
UxxC
240
U
258
U
299
U
311 324
apoER2
binding
site
326 349 358
C-terminal
333 347 356 361
U U UxUUxU
Figure 1. Mouse and human selenoprotein P. (a) Mouse Sepp1 after removal of the signal peptide. The N-terminal region includes the redox site [40–44], and
heparin binding sites [79–86]. The Sec-rich C-terminal region includes the apoER2 binding site (dashed line: exact position unknown) and remaining Sec positions.
U (in red) signifies sites of selenocysteine specification. (b) Selenoprotein P products. Ultra-short form terminates before UGA 1 at residue 40 and is undetected by
the 9S4 antibody; short form progresses beyond residue 40 and does not include the apoER2 site; and long form extends beyond residue 324 and includes the
apoER2 binding site. (c) Human selenoprotein P canonical forms and transcript variants with indication of regions that the designed qPCR primer pairs A1, A2, B1,
B2 and C amplify. (d ) Sepp1 transcript variants mRNA fold induction. Transcript quantification after normalization with GAPDH and 0 nM Se treatment. Primer pairs
A1, A2, C1: long and short isoforms; Primer pairs B1, B2: long isoforms. Values are mean+ s.e.m., n ¼ 3.
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Following translation by the leading ribosome, the extent of
proximity of the following ribosome probably influences
whether it encounters a refolded SRE. Thus the efficiency of
selenocysteine specification is potentially modulated by the
extent of ribosome loading. On the occasions when synthesis
of selenoprotein S terminates at UGA just 50 of the full-length
coding sequence terminator, the product is susceptible to
degradation by the ubiquitin ligase CRL2 [38]. These findings
also support the desirability of investigations with the native
selenoprotein gene context.
Knowledge of Sepp1 is relevant to the recent adoption
in Germany, Austria and Switzerland of the saturation of
Sepp1 in plasma as a criterion for the derivation of reference
values for selenium intake in adults [56], and its likely future
adoption in other countries.
Further to the importance of selenoprotein P, there are intri-
guing aspects to how this extreme case of recoding occurs.
Despite both ciliates and mammals having evolved the ability
to limit selenocysteine insertion to natural positions within sele-
noproteins and to do so in a selenoprotein mRNA-specific
manner controlled by the SECIS element in the 30 UTR [57,58],
it is still widely thought that a SECIS element will cause
selenocysteine specification at any UGA in its coding sequence.
This study suggests Sepp1 SECIS functions with site speci-
ficity and further illustrates how mRNA processing may
produce transcripts with altered coding potential to produce
diversity in selenoprotein isoforms.
2. Material and methods
2.1. Bioinformatic discovery and quantification of
alternative transcript isoforms
Alternative transcript isoforms for Sepp1 and selenoprotein S
genes were searched using various data sources. One was a
map of polyA sites inferred by sequencing with a protocol
specifically developed for this purpose (polyA-Seq) [59].
These data span multiple tissues in five mammals (electronic
supplementary material, figure S1d ). Importantly, this sequen-
cing protocol permits distinction of the source strand of the
RNA reads. This can yield accurate strand quantification and
exclude the potential confounding factor of reads coming
from overlapping genes. This is relevant since the 30 UTR of
Sepp1 partially overlaps gene CCDC152 on the opposite
strand, making quantification of the 30 variants of Sepp1 prac-
tically impossible without strand information. Alternative
polyA sites inferred by polyA-Seq were first inspected in the
UCSC genome browser [60]. Then the raw quantification
values were downloaded from the Supplementary materials
of Derti et al. [59] and manually inspected.
Secondly, the human tissue-specific quantifications from
the Genotype-Tissue Expression consortium (GTEx) [61] were
considered. The expression values across human tissues of the
exons and exon junctions annotated for selenoprotein S were
extracted, plotted and finally compared with the polyA-seq
quantification. As the RNA-seq protocol used in GTEx was
not strand-specific, these data could not be used for quantifi-
cation of the 30 UTR variants in selenoprotein P. However, the
GTEx data allowed us to profile the expression across human
tissue variants in the rest of the gene structure (electronic
supplementary material, figures S1B, S1C, S2B and S2C).
2.2. Bioinformatic analysis of SECIS elements
Selenoprotein P genes were identified in vertebrate genomes
using the program SELENOPROFILES [62]. Their SECIS elements
were identified by scanning the sequences downstream of
the coding sequences using SECISEARCH3 [63]. The SECIS
sequences were aligned with T-COFFEE [64], and then visualized
using JALVIEW [65]. The predicted phylogenetic tree of
SECIS elements was computed based on sequence identity,
using the average distance method available within JALVIEW
(electronic supplementary material, figure S3b).
2.3. Experimental analysis of selenium supplementation
in tissue culture cells
Human hepatic carcinoma cell lines (HEPG2) were cultured
and selenium supplemented following a previously pub-
lished protocol [66]. Total RNA and genomic DNA (gDNA)
were then isolated from cells seeded at a density of around
0.8  106 in a 60 mm cell culture dish. Three cell culture repli-
cates were produced to generate data points. RNA was
isolated as per manufacturer’s protocol using RNeasy mini
kit from Qiagen (74104) and gDNA was isolated as per man-
ufacturer’s guidelines using Purelink genomic DNA mini kit
from Invitrogen (KI820-01). Total RNA was run on an agar-
ose gel to determine RNA integrity. Total RNA and gDNA
quantity and purity were determined by spectrophotometry
using the Nanodrop 1000 from Thermo Scientific. RNA was
equalized to 2 mg per reaction, treated with RQ1 Promega
DNase and reverse transcribed into complementary DNA
(cDNA) using Superscript III first strand synthesis system
from Invitrogen (18080051). gDNA was also equalized to
2 mg per reactions. Real-time qPCR experiments were carried
out by equalizing template cDNA and gDNA to 66.7 ng per
reaction per well. Reactions (20 ml) were carried out in triplicate
with each containing a mixture of 4 ml template, 10 ml SYBR
green Fast Start Essential DNA Green Master from ROCHE
(06402712001), 1 ml PCR grade water and 1 ml each of 10 mM
stock forward and reverse primers. Primers were synthesized
by Integrated DNA Technologies and the sequences are listed
in the electronic supplementarymaterial, table S1a. All reactions
were performed in triplicate. Non-reverse-transcribed controls
were also amplified to ensure that the RNA used was free
from gDNA contamination.
Primerefficiency to targetbindingwasdeterminedusingTm
melting peak analysis and agarose gel electrophoresis. Ct values
from cDNA were normalized against Ct values of gDNA/
GAPDH cDNA to compensate for variations of input RNA/
cDNA and differences in reverse transcription efficiency. Rela-
tive mRNA-fold induction was calculated using the DDCT
method on the normalized values. Changes in expression of
each transcript variants at different selenium concentration
were expressed as mRNA fold induction divided by mRNA
fold induction values at 0 nM added selenium concentration
for each of the primer pairs.
2.4. Generation of Sepp1DSECIS1 and Sepp1DSECIS2 mice
Themethod used was described previously [67], and construct
features are illustrated in figures 2 and 3. We first used recom-
bineering to subclone a 13.1 kb genomic fragment from a BAC
clone RP23-41H17, which was obtained from the BACPAC
rsob.royalsocietypublishing.org
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Figure 2. Generation of a knockout mouse line, Sepp1DSECIS1, that has deleted the first SECIS signal of the Sepp1 gene. To generate the Sepp1DSECIS1 allele, a genomic
fragment (red line) containing sequence from 50-CTGAAGCAACAGCTAAAAGA-30 to 50-AACACTCCATGCAAACTACA-30 of the Sepp1 gene was used for constructing the targeting
vector. (a) Genomic structure of the WT Sepp1 gene, with its five exons shown in green. The 30 UTR sequence is shown, with the sequence shown in red being that of SECIS
2. (b) In the targeting vector, a self-excising neo cassette (Ace-Cre-neo, also named ACN) was used to replace the SECIS 1 sequence. (c) During the cross between chimaeric
males and WT females, the ACN neo cassette is deleted automatically, resulting in a clean heterozygous Sepp1DSECIS1 allele.
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Figure 3. Generation of a knockout mouse line, Sepp1DSECIS2, that has deleted the second SECIS signal of the Sepp1 gene. To generate the Sepp1DSECIS2 allele, a
genomic fragment (red line) containing sequence from 50-CTGAAGCAACAGCTAAAAGA-30 to 50-AACACTCCATGCAAACTACA-30 of the Sepp1 gene was used for
constructing the targeting vector. (a) Genomic structure of the WT Sepp1 gene, with its five exons shown in green. The 30 UTR sequence is shown,
with the SECIS 2 signal highlighted in blue. (b) In the targeting vector, a self-excising neo cassette (Ace-Cre-neo, also named ACN) was used to replace the
SECIS 2 sequence. (c) During the cross between chimaeric males and WT females, the ACN neo cassette is deleted automatically, resulting in a clean heterozygous
Sepp1DSECIS2 allele.
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resources (http://bacpac.chori.org/). The two oligos used
in this step (electronic supplementary material, table S1b)
were WS785 and WS786. The resulting plasmid from this
step was named pStartK-Sepp1. We next designed two
oligos WS1214SECIS1camF and WS1215SECIS1camR to PCR
amplify pKD3 which contains a chloramphenicol resistance
gene (cat). The PCR product was used for recombineering
with the plasmid pStartK-Sepp1.
In the correctly recombined clones, the SECIS 1 sequence
was now replaced by a BamHI flanked cat. The cat gene was
then cut out by BamHI digestion, and a BglII flanked neo
selection cassette was inserted. The resulting plasmid is
named pStartK_Sepp1_dSECIS1_ACN. Similarly starting from
pStartK-Sepp1 (above), we designed two oligos WS789 and
WS790 (electronic supplementary material, table S1b) to PCR
amplify pKD3 which contains a chloramphenicol resistance
gene (cat). The PCR product was used for recombineering
with the plasmid pStartK-Sepp1. In the correctly recombi-
ned clones (named pStartK-Sepp1-789), the second SECIS
sequence was now replaced by a cat gene flanked by BamHI
restriction sites. The cat gene was then removed by BamHI
digestion, and a BglII flanked neo selection cassette (designa-
ted ACN) was inserted. The resulting plasmid was named
pStartK-Sepp1-dSECIS2-ACN.
To add a negative selection HSV-tk gene, Gateway recombi-
nation is performed to quickly transfer the modified Sepp1-
ACN into an HSV-tk containing vector named pWSTK6. The
resulting targeting vectors are named pWSTK6-Sepp1-dSECIS1
and pWSTK2-dSepp1-dSECIS2, respectively. Standard electro-
poration of linearized targeting vector into ES cells was
performed as described [67]. Southern blot analysis was per-
formed to identify correctly targeted ES cell clones. The 30
Southern probe template (301 bp) was amplified by PCR from
the BAC clone RP23-41H17 with primers WS871Sepp1-3F and
WS872Sepp1-3R (electronic supplementary material, table S1b).
DNA isolated from ES cells was digested with BamHI, and run
on a 0.9% agarose gel.
A Southern blotwas performedwith the 30 probe. Thewild-
type (WT) band is 15.7 kb for both SECIS 1 and 2, and targeted
mutant band is 5.1 kb for SECIS 1 and 4.6 kb for SECIS 2. The
positive targets were further confirmed by long-range PCR.
2.5. Generation of Sepp1U59S mice to give U40S after
signal peptide removal
To construct the targeting vector for Sepp1U59S, we started from
pStartK-Sepp1 (above). We used PCR-based mutagenesis to
convert the DNA encoding the first selenocysteine from TGA
to TCA, which now encodes serine. We then inserted the self-
excising neo selection cassette ACN in the BglI site before the
second exon. The resulting plasmid was named pStartK-Sep-
p1U59SACN. To add a negative selection HSV-tk gene,
Gateway recombination was performed to quickly transfer
Sepp1U59SACN into an HSV-tk containing vector named
pWSTK2. The resulting targeting vector was named
pWSTK2-Sepp1U59SACN. Standard electroporation of the
linearized targeting vector into ES cells was performed as
described [67]. Southern blot analysis was performed to ident-
ify correctly targeted ES cell clones. The 50 Southern probe
template (476 bp) was amplified by PCR from the BAC clone
RP23-41H17 with primers WS869 and WS870 (table S1b).
DNA isolated from ES cells was digested with BamHI, and
run on a 0.9% agarose gel. Southern blot was done with the
50 probe. The WT band is 15.7 kb, and targeted mutant band
is 6.9 kb. The positive targets were further confirmed by
Southern blot analysis with XbaI digest, 50 probe.
2.6. Blastocyst injection and mouse breeding
Targeted ES cells for Sepp1DSECIS1, Sepp1DSECIS2 and Sepp1U59S
were injected into blastocysts using a standard protocol. Male
chimaeric mice were bred with C57BL/6 females to obtain
the desired alleles. As we used the self-excising neo cassette
ACN, the neo was automatically deleted in the F1 generation
of heterozygotes.
3. Results
3.1. Alternative transcripts for human Sepp1
To explore possible natural variants of Sepp1 mRNA with
differing 30 UTRs, we searched for alternative transcript var-
iants of Sepp1 genes. A global map of polyA sites in multiple
tissues of five mammals: human, rhesus, dog, mouse and rat
[59] was first used. In all species, the major polyA site pre-
dicted for Sepp1 was ‘canonical’, located just downstream
of SECIS 2. In dog, rhesus and human, a second polyA site
was identified, further away. This site is predicted to result
also in canonical mRNA, carrying both SECIS 1 and 2. Inter-
estingly, we found an additional, well-supported alternative
site in human and rhesus, not present in dog, mouse and
rat (electronic supplementary material, figure S1d ). This site
resides in between the two SECIS elements, and thus
would result in mRNAs lacking SECIS 2 (figure 1c). The site
was observed in all human and rhesus tissue samples. Its
quantification relative to the major canonical form was similar
across tissues, ranging from 10 to 25% in dispersed humans,
and from 0.5 to 9% in rhesus. This variant is produced in
similar proportions across tissues.
Additionally, we searched the expression profiles generated
for the GTEx project, derived from post-mortem samples of
various human tissues [61]. Although it was not possible to
quantify in these profiles the 30 UTR variants (see Material and
methods), we could obtain expression profiles for other Sepp1
mRNA variants. In particular, we observed usage of a non-
coding alternative first exon located approximately 13.5 kb
upstreamof the first exon in the canonical form (see the electronic
supplementary material, figure S1a). This alternative first exon
was detected specifically in blood and liver, where, nevertheless,
it still constitutes onlyaminor fractionof the total Sepp1mRNAs,
among which the canonical form predominates. The expression
analysis also highlighted usage of two cassette exons located
between the first and second exons of canonical Sepp1 mRNA
(electronic supplementary material, figure S1a and figure 1c).
The first cassette exon was detected at very low levels in all tis-
sues. The second cassette exon was detected specifically in the
small intestine, liver, kidney and transverse colon, but again
only as a minor fraction of the amount of the canonical mRNA
(electronic supplementary material, figures S1b,c).
To quantify the different mRNA variants upon selenium
supplementation, we designed multiple primer pairs targeting
either the region specific to the longvariantwhich contains both
SECIS 1 and SECIS 2 (B1 and B2), or common parts namely the
long variant and the recently identified short variant lacking
SECIS 2 (A1, A2 and C; electronic supplementary material,
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table S1 and figure 1c). An issue with this approach is that the
30 UTR of Sepp1 overlaps with another gene on the opposite
strand. While A1, A2, B1 and B2 map to the overlapping
region, C is upstream and thus works as a control for the A
primers. The differences in transcript expression between A1/
A2/C and B1/B2 primers would indicate the proportion at
which the two distinct mRNAs are expressed. The HEPG2 cell
line was cultured in media supplemented at different selenium
concentrations. Liver was chosen since it is the tissue with the
highest Sepp1 expression, and considered the major ‘exporter’
of selenium to other tissues. Ct values of the cDNA for each
sample were normalized to GAPDH cDNA values. A second
normalizationwas performed against the 0 nMadded selenium
values. In general, each of the primers shows a multiphasic dis-
tributionwhichwas not reported previously. A first bell-shaped
distribution of Sepp1 transcript expression was observed fol-
lowed by a second point of increase at a higher selenium
concentration. This finding suggests that although the different
Sepp1 transcript variants are likely regulated by increasing
selenium concentration, no difference in the distribution of
long and short transcripts was observed (figure 1d).
3.2. Generation of mutant mice and characterization
of their Sepp1
Multiple selenocysteine specifying UGA codons and two
SECIS elements in its 30 UTR (instead of one) make selenopro-
tein P mRNA unique, with alteration of these features likely
informative about the nature of the decoding and the forms
of the products secreted into plasma. We generated mutant
mice by the procedures described in the Material and
methods section. One mutant had SECIS 1 deleted and
replaced by a loxP site (figure 2), and another had SECIS 2
similarly deleted (figure 3). The third mutant had the first
UGA substituted with a serine codon (figure 4). Plasma
Sepp1 forms were then studied in the resulting mice.
Plasma selenium biomarkers (Sepp1 concentration, gluta-
thione peroxidase (Gpx) activity and selenium concentration)
were quantified. Over 97% of plasma selenium is present in
two selenoproteins—Sepp1 (approx. 80%) and Gpx-3
(approx. 18%)—in mice fed the element as selenite [18,19].
Sepp1 was isolated from plasma using the antibody 9S4
and its selenium content was determined. In addition, it
was subjected to SDS-PAGE analysis. Attempts to character-
ize Sepp1 forms with mass spectrometry were difficult to
interpret because of the large number of forms that were
present. Those results will not be reported here.
3.3. Mutation of the first selenocysteine to serine
The first selenocysteine residue of Sepp1 is distinguished by its
location remote from the other nine residues (figure 1a). Because
UGA1must be translatedbefore theotherUGAs, itwasmutated
to a serine codon to allow us to determine whether its presence
affected other aspects of Sepp1 synthesis and secretion.
Some of the characteristics of U40S homozygous mice have
been published elsewhere. They had no obvious clinical
abnormalities and tolerated severe selenium deficiencywithout
developing the neurological signs observed in homozygous
Sepp1 deletion mice fed a selenium-deficient diet [68].
U40S homozygote mice had twice as much Sepp1 in their
plasma as did congenic WT littermates but only 66% as much
selenium (figure 5a). Gpx activity was not affected and
neither were selenium levels in liver, kidney, brain, testis,
quadriceps and the whole body (results not shown).
Forms of plasma Sepp1 fromhomozygousU40Smice had a
different SDS-PAGE migration pattern from that of WT forms.
The protein fromWTmicemigrated as a broad band extending
from approximately 50 kDa to approximately 45 kDa and a
Sepp1 WT
Sepp1U59S
targeted ES cells
Sepp1U59S
Mice
ATGBamHI BamHI
ATGBamHI
5' probe
BamHI BamHI BamHI
ATGBamHI BamHIBglI
loxP loxP
Ace-Cre-neo
loxP
WS1005
WS1004
1 2 3 4 5
1
2 3
4 5
1 kb(a)
(b)
(c)
1 2 3 4 5
Figure 4. Generation of a mouse line with Ser in place of the first selenocysteine (Sec). A genomic fragment (highlighted in red) containing sequence from 50-CTGAAG-
CAACAGCTAAAAGA-30 to 50-AACACTCCATGCAAACTACA-30 of the Sepp1 gene was used for constructing the targeting vector. (a) Genomic structure of the WT Sepp1 gene,
with its five exons in green. The second exon contains the start codon ATG. Sepp1 has 10 selenocysteines encoded each by a UGA codon. The first of the 10 TGAs that can
specify selenocysteine is located within the second exon. The remaining nine TGA sequences are located in exon 5. (b) After homologous recombination in the ES cells, one
copy of the endogenous Sepp1 gene is replaced by the modified sequence in the targeting vector, which has the first TGA (Sec) changed into TCA (Ser) and a self-excising
neo cassette (Ace-Cre-neo, also named ACN) inserted into the BglI site between first and second exons. (c) During the cross between chimaeric males and WT females, the
ACN neo cassette is deleted automatically, resulting in a clean heterozygous allele Sepp1U59S. U40S referred to below is after the signal peptide is removed.
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much lighter band at approximately 37 kDa (figure 6, lane 1).
The predominant Sepp1 from U40S mice migrated at 37 kDa
and another, also dense, product migrates even farther
(figure 6, lane 2). A third, but less dense, product migrated
just below 50 kDa, but above the other two products. These
observations indicate that the Sepp1 forms from U40S mice
plasma are, on average, smaller than those making up WT
plasma Sepp1.
The purified preparation of Sepp1 from U40S mice con-
tained an average of 1.6 selenium atoms per molecule—many
fewer than the 5.8 atoms per molecule contained in the
WT preparation (table 1). In a separate experiment, the sel-
enium atoms per WT Sepp1 molecule in each of the three
Sepp1-containing bands were estimated. Aliquots of a single
preparation of Sepp1 were applied to four lanes of an SDS-
PAGE gel. The three bands were scanned for density and cut
from each lane. Selenium was determined in each band.
Sepp1 in each band was estimated by multiplying the amount
of Sepp1 applied to the lane by its fraction of the density of
all three bands. The products—fromupper to lower—were esti-
mated to contain 2.5+0.8, 0.20+0.12 and 0.06+0.05
selenium atoms per Sepp1 molecule, respectively. The value
of 0.20 from the middle U40S mouse product is taken to
imply that only amodestminority of decoding events involving
the first UGA results in selenocysteine rather than an amino acid
such as cysteine or serine being specified.
These findings indicate that many of the forms of Sepp1
from U40S mice lacked some, or all, of the selenium-rich C-
terminal domain and, possibly, some of their carbohydrate. It
is clear, however, that some Sepp1 forms reaching to residues
324–326 were present because those residues are required for
the interaction with apoER2 responsible for selenium distri-
bution to extra-hepatic tissues and for protection of brain
neurons under selenium-deficient conditions. Also, mutation
of the first UGA to UCA resulted in a doubling of Sepp1
forms (mostly the shorter ones) in plasma, probably indicating
an increase in mutant Sepp1 synthesis.
3.4. Deletion of the second SECIS element
SECIS 2 was deleted to assess the effect of its absence on
plasma Sepp1 and on selenium transport to tissues. Homozy-
gous SECIS 2 deletion mice appeared healthy and had no
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Figure 5. Plasma selenium biomarkers of mutant selenoprotein P gene mouse strains. (a) U40S; (b) DSECIS 2; (c) DSECIS 1. Values are means þ 1 s.d., n ¼ 5.
Pairs of values with percentages above them are different ( p , 0.05) by Student’s t-test.
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Figure 6. Analysis of selenoprotein P preparations from plasma of the
mutant mice strains by SDS-PAGE. Numbered lanes contain preparations:
lane 1, WT; lane 2, U40S; lane 3, DSECIS 2; lane 4, DSECIS 1. M indicates
molecular weight markers. Plasma from each mouse was passed through a
column containing a monoclonal antibody (9S4) against the N-terminal por-
tion of Sepp1. Then a Sepp1 fraction was eluted. The amount of Sepp1
fraction that contained 2 mg of protein was loaded onto each lane.
Table 1. Selenium atoms per molecule of selenoprotein P preparations
from plasma of the mutant strains (WT, wild-type).
mouse strain selenium atoms/selenoprotein P moleculea
WT 5.7, 5.9
U40S 1.4, 1.7
DSECIS 2 6.4, 8.1
DSECIS 1 1.0
aEach value is from a preparation of selenoprotein P from different mice.
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obvious clinical abnormalities. They tolerated severe selenium
deficiency, caused by feeding a selenium-deficient diet for 36
weeks after weaning, without developing neurological signs
(data not shown).
Plasma from homozygous SECIS 2 deletionmice contained
only 15% as much N-terminal Sepp1 as did plasma from WT
littermates (figure 5b) and plasma Gpx activity was 76% that
of the WT littermates (not shown). In spite of the very low
Sepp1 and the decrease in Gpx activity, plasma selenium was
58% of that inWT littermates. The liver selenium concentration
in the SECIS 2 deletion mice was 113% that of WT littermates
but selenium concentrations in other tissues and the whole
body were not significantly different from those of WT
littermates (not shown).
The Sepp1 N-terminal forms migrated in one band on the
SDS-PAGE gel (figure 6, lane 3). That band corresponded to
the upper band of WT plasma (lane 1). Purified Sepp1 from
SECIS 2 deletion mice contained an average of 7.2 atoms of
selenium per molecule (table 1).
These findings indicate that deletion of SECIS 2 leads to a
sharp decrease in total plasma Sepp1 forms and a shift to
long-form Sepp1 molecules. The decrease in plasma Gpx
activity is consistent with a decrease in short form Sepp1,
which supplies selenium to the kidney.
3.5. Deletion of the first SECIS element
Deletion of the first SECIS element hadmajor effects on plasma
Sepp1 and on transport of selenium from the liver to peripheral
tissues. The plasma selenium concentrationwas 26% of theWT
value, although Sepp1 concentration fell only to 75% (figure 5c)
and Gpx activity was not affected (not shown). Tissue concen-
trations of selenium were decreased in the tissues that depend
on apoER2-mediated endocytosis of long forms of Sepp1 for
their supply of selenium (figure 7). Kidney selenium, which
depends on megalin-mediated endocytosis of short form
Sepp1 for its selenium, was not affected.
Homozygous SECIS 1 deletion mice did not tolerate sel-
enium deficiency. Four such male weanling mice were fed a
selenium-deficient diet and four were fed the same diet sup-
plemented with 0.25 mg selenium per kilogram (control diet).
None of the mice fed the selenium-deficient diet survived
beyond four weeks, whereas all those fed the control diet
appeared healthy. One selenium-deficient mouse was sacri-
ficed at two weeks because it had severe impairment of gait
and had also developed hyperactivity. Another one had lost
31% of its body weight by two weeks and was sacrificed.
A third mouse became severely hyperactive and was sacrificed
at three weeks and the fourth developed gait impairment
at two weeks that progressed; it was found dead at four
weeks (table 2).
In a separate experiment, four weanling female homo-
zygous SECIS 1 deletion mice were fed a selenium-deficient
diet and three were fed a control diet. Three of the mice fed
Table 2. Summary of ﬁndings in selenoprotein P homozygous mouse strains.
WT D1–361 D240–361 U40S DSECIS 2 DSECIS 1
Plasma
selenoprotein P
control 0% 145% 200% 15% 75%
plasma Sea control 18% 47% 66% 58% 26%
plasma Gpxa control 100% 100% 100% 76% 100%
Se atoms/
selenoprotein P
5b — 1.0 (mass spec) 1.6 7.3 1.0
tissue Sea control decreased in tissues
dependent on
apoER2
decreased in tissues
dependent on
apoER2
no effect no effect decreased in tissues
dependent on
apoER2
forms on gela mostly long
with some
short
— only short increased
short
only long increased short
neurological injury
with 0 Se
no yes yes no no yes
aCompared with WT littermates.
bPlasma biomarkers are from unpublished results and other ﬁndings are from Hill et al. [47].
95%
33%
77%
mutant
WT
Sepp1DSECIS 1/DSECIS 1
75%63%
se
le
ni
um
 (n
g g
–
1 )
liver
1000
500
0
kidney brain testis muscle whole
body
Figure 7. Effects of deleting SECIS 1 element on tissue selenium concen-
trations. Mice were fed control diet from weaning and were studied four
weeks after weaning. Values are means þ 1 s.d., n ¼ 5. Pairs of values
with percentages above them are different ( p, 0.05) by Student’s t-test.
rsob.royalsocietypublishing.org
Open
Biol.6:160241
9
 on March 28, 2018http://rsob.royalsocietypublishing.org/Downloaded from 
the selenium-deficient diet developed neurological signs that
were less severe than those seen in the males. One was sacri-
ficed at four weeks and the other two at five weeks. The
fourth mouse fed a selenium-deficient diet remained without
neurological signs at five weeks, as did the three mice fed the
control diet. The neurological impairment that was seen in
males and in females was typical of that seen in homozygous
Sepp1 deletion mice fed a selenium-deficient diet [69].
The Sepp1 fraction obtained from the SECIS 1 deletion
mouse plasmawas subjected to SDS-PAGE in a separate exper-
iment and the result is shown in figure 6, lane 4. The dominant
protein is at the 67 kDa position and migrates with albumin.
The predominant product migrating slower than the 50 kDa
position appears at the 37 kDa position instead of just below
50 kDa, where long forms of Sepp1 would be expected. An
even less dense band is visible below that reflecting the
37 kDa product. The presence of significant protein contami-
nation, as indicated by the 67 kDa protein, is compatible with
very low Sepp1 amounts being in the 2 mg sample loaded.
A possible explanation is that the plasma contained very
low amounts of Sepp1 forms that bound 9S4.
The one preparation available for selenium analysis con-
tained an average of 1.0 selenium atom per molecule (table 1).
Because the Sepp1 preparation from the SECIS 1 deletion
strain containedmore contaminants than the other preparations
(figure 6, compare lane 4 with lanes 1–3), its Sepp1 likely
contains more than 1.0 selenium atom per molecule.
In summary, deletion of SECIS 1 had striking effects. It
caused a sharp decrease in plasma Sepp1 and also in sel-
enium concentration of tissues expressing apoER2, but not
in kidney, which expresses megalin. This strongly suggests
that it drastically decreased long-form Sepp1 while having
a lesser effect on short-form Sepp1.
4. Discussion
4.1. Isoform diversity
Exploration of the mechanism of decoding multiple UGAs as
selenocysteine has been accompanied by identification here of
previously unrecognized diversity in selenoprotein P mRNAs.
Further to polyA-Seq analysis showing alternative forms
of Sepp1 mRNA, it is notable that one human Sepp1
mRNA variant has been found to lack SECIS 2. This shorter
form of human Sepp1 mRNA that lacks SECIS 2 is present
in lower abundance than the canonical form, and interest-
ingly no difference in the ratio in different tissues has been
detected. The only prior report of a eukaryotic selenoprotein
mRNA lacking a SECIS was selenoprotein S [21] and in that
case it was the sole SECIS element. With polyA-Seq data [59],
we confirmed the presence of distal polyA sites consistent
with the SelS SECIS-lacking variant mRNA (electronic sup-
plementary material, figure S2A). However, our analysis of
these data did not reveal the tissue specificity we separately
detected with GTEx data where the isoform was detected at
low levels in all tissues, but it showed a high expression
peak in the testis samples. Instead proportionate expression
of the SECIS-lacking and the canonical form of SelS mRNA
appears to be roughly the same across the samples from
different tissues, including testis-derived samples (electronic
supplementary material, figure S2b,c). We did not experimen-
tally address whether presumptive regulation of SelS may
be linked to some condition such as selenium availability.
Future work will need to address potential functional signifi-
cance of these two forms and extend analysis of the 30 variant
lacking the sole SECIS studied previously [21] and also here.
While much remains unknown about how SECIS elements
in the 30 UTR inform translating ribosomes that UGA in that
mRNA is to specify selenocysteine, even less is known about
whether it is associated with selenoprotein 30 poly(A) interact-
ing in a closed-loop arrangement to facilitate re-initiation
involving specialized components. While there are precedents
in unrelatedmRNAs for considering such loops [70–75], itmay
be pertinent that at least several selenoprotein mRNAs have
unusual 50 cap structures [76] and initiation factors have
some level of specific relevance for selenocysteine specification
[77].Whether significant selenoproteinmRNA closed-loop for-
mation occurs is unknown. Such considerations could be
relevant to the existence of truncated isoforms.
Because selenoprotein P has at least two functions and
has multiple forms it is possible that cells can regulate the
forms they produce. The transport function of mammalian
selenoprotein P appears to reside in hepatocytes because
90% or more of plasma Sepp1 is produced by them [45].
Most cell types express Sepp1 but the forms they produce
have not been characterized.
Monitoring the ratios of the distinct mRNA forms in hepa-
tic carcinoma cells with varying selenium levels revealed
unexpected first evidence for Sepp1 multiphasic expression.
There is first a bell-shaped distribution of Sepp1 expression,
with a second point of increase at high selenium concentration.
A multiphasic distribution was not reported in older papers
reporting similar experiments [66]. However, that work
involved northern blots and development since then of the
more sensitive qPCR used in this work is probably relevant
to this difference. The sharp fluctuation of transcript levels
also seems to be very sensitive to changes in concentration,
and so a fine range of concentrations is also likely important.
More recent studies performed in rodents using qPCR
revealed increasing Sepp1 mRNA in response to selenium con-
centrations which then plateaus off at super-nutritional levels
tested, eight times fold higher than required (0.08, 0.24, 0.8. 2
and 5 mg g–1 of body weight) [78]. The concentration range
tested in our experiments is within normal levels required in
humans with maximum values enough to induce toxicity
(0, 1, 2, 5, 10, 20, 50 and 100 nM). The mRNA expression for
all the transcript variants start to drop at selenium levels con-
sidered optimum (10–20 nM) and a late increase was further
observed at toxic concentration (100 nM). It is possible that in
the rodent studies, key concentrations required to display the
multiphasic response are missed. Another important point to
note is that underlying selenium regulation is further compli-
cated due to an often huge discrepancy between selenium
metabolism in intact animals versus cultured cell models.
Futureworkwill need to assess thegeneralityof the initial obser-
vation reported here, and address thepossibility that in addition
to the known role of Sepp1 in selenium transport to different tis-
sues, at very high selenium levels Sepp1 levels may again
increase but now to facilitate excretion and detoxification.
Although no evidence for selenium concentration
dependent alteration of isoform ratio was obtained, future
experiments may reveal stress or other conditions in which
ratio alteration occurs and has functional significance (Sepp1
reduces oxidative stress in vivo by an unknown mechanism).
Though WT mice lack a natural isoform with SECIS 1 but
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without SECIS 2, we generated a mouse in which the sole
Sepp1 gene lacked SECIS 2 and analysed its phenotype when
fed different levels of selenium in its food.
4.2. SECIS and U40S mutant mice
The mice in which the second SECIS element was deleted had
only 15% as many molecules of Sepp1 in their plasma as WT
but it was almost exclusively ‘longform’. As used above,
‘longform’ includes the apoER2 binding site specified by
codons 324–326 and is distinct from the short forms syn-
thesized by ribosomes that do not extend to codon 326. As
UGA 5 is codon 311, this long-form Sepp1 normally has mul-
tiple selenocysteines. Under standard cage conditions, these
mice had normal tissue selenium levels and tolerated selenium
deficiency without neurological injury. Determination of the
likely significance of the newly identified human isoform
lacking SECIS 2 will require considerable future work.
Plasma Sepp1was analysed earlier fromWTmice fed a sel-
enium-deficient diet [79,80]. The efficiencyofUGA redefinition
is modulated by selenium availability [37], as is the expression
of several selenoprotein mRNAs. Since only low levels of
plasma Sepp1 are seen in mice fed on a selenium-deficient
diet, the Sepp1 analysis for presentation here was only per-
formed on mice fed a selenium-replete diet. Also relevant is
that especially at low selenium concentrations, the selenocys-
teine tRNA and the SECIS machinery can cause UGA to
specify cysteine [41,81]. Sepp1 is synthesized and processed
inside cells before being secreted into the plasma. Our obser-
vations (figure 8) were made on extracellular protein and,
therefore, reflect transcriptional, mRNA processing and stab-
ility influences on mRNA levels as well as translation,
protein processing and export. As selenocysteine specification
is in competition with standard decoding in which UGA is a
stop codon, mRNA decay is especially relevant. There is a con-
served exon–intron junction 30 of UGA 1; it is only 26 nt distant
and sowell under the 50 nt minimal spacing ‘rule’ required for
canonical nonsense-mediated decay susceptibility. The level of
Sepp1mRNA is lower in selenium-deprived conditions than in
replete conditions, but its proportionate increase is much less
than that of its glutathione peroxidase 1 and selW counterparts
which are also much more sensitive to nonsense-mediated
decay [24,82–86]. Major aspects on nonsense-mediated decay
effects remain to be resolved and are outside the scope of the
present work as are other types of mRNA decay, notably No-
go decay [25], which could be potentially relevant when ribo-
somes pause at UGA. Though SECIS-binding protein 2 binds
Sepp1 less avidly than many other selenoprotein mRNAs
[84], it plays a major role in protecting Sepp1 mRNA from
decay [31,46]. (It also binds to SECIS elements [26], preferen-
tially to SECIS 1 [84].) All three mutants studied here show
less than a 25% difference in Sepp1 mRNA levels from their
WT counterpart (data not shown). Because there are many
Sepp1 forms, it is possible that some of those translated
might not survive processing, by the ER and Golgi apparatus,
to be secreted.However, the findings do show that SECIS 1 and
SECIS 2 have different effects on enabling ribosomes to decode
UGA as selenocysteine, and that either the location in the
mRNA or whether the UGA is the first, second or third in
relation to the other UGAs, affects the efficiency of
selenocysteine specification.
In mice with UGA 1 and SECIS 2 present but with SECIS
1 deleted, there is a 25% reduction of plasma Sepp1 from that
of WT. The decrease may be due to processing or differences
in turnover. Alternatively, it could reflect the proportion of
SECIS 1-mediated selenocysteine specification at UGA 1 in
WT. That SECIS 1 must be able to act at UGA 1 in the absence
of SECIS 2 is shown by the presence in the SECIS 2 deletion
mice of 15% of the amount of Sepp 1 present in WT mice.
Nearly this entire product is present in long form with
implications for different SECIS 1 action at downstream
UGAs than occurs with WT mRNA. We strongly favour the
interpretation that SECIS 1-mediated selenocysteine specifica-
tion at UGA 1 leads to greater ribosome specialization at that
site than occurs with SECIS 2. The results also suggest that
most of the Sepp1 product in plasma in WT mice derives
from SECIS 2 rather than SECIS 1 being involved in decoding
UGA 1, with SECIS 1 normally being involved in decoding
subsequent UGAs. Thus, the present results broadly support
the Berry model for SECIS 1 and SECIS 2 roles derived from
the very different approach of directly assaying Sepp1 from
zebra fish Sepp1 sequences fused to GST and expressed in
transiently transfected mammalian cells [13]. In vitro trans-
lation in both rabbit reticulocyte lysates [14] and in wheat
germ lysates [15] also broadly supported the Berry model.
One deduction from the earlier construct-based work was
that Sec incorporation at the first UGA codon is inefficient,
whereas Sec incorporation at downstream UGAs occurs with
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increased efficiency. Our SECIS 1 and SECIS 2 mutant studies
also support this, and the results frommicewith UGA 1, codon
40, substituted with a serine codon (U40S) are also relevant.
With U40S, all ribosomes would be expected to progress to
codon 240 where they would encounter their first UGA (the
position of UGA 2 in WT). The amount of plasma Sepp1 was
twice as much as in WT. Presumably on reaching UGA 1
some ribosomes terminate instead of incorporating selenocys-
teine and continuing translation. The unknown proportion of
such early terminating ribosomes may be relevant to elevated
Sepp1 with U40S, though possible slow decoding of UGA 1
could also be pertinent if it leads to a ribosome pile-up that
could affect initiation. If indeed a substantial proportion of
ribosome specialization occurs at UGA 1 in WT, UGA 1
could be slower to decode than downstream UGAs. However,
additionally in U40S mice, evenwith both SECIS elements pre-
sent, most of plasma Sepp1 was present in truncated forms
(short forms). While the products may conceivably be more
stable and so more detectable than their WT counterparts, it
seems more likely that the absence of UGA 1 location-specific
ribosome specialization is the cause of the disproportionate
increase of short forms compared with full-length forms.
(Notably, however, mice engineered to express only the
N-terminal domain, with deletion of codons 240–361 and so
SECIS 1 not involved in decoding UGAs after UGA 1, had a
Sepp1 plasma level of 145% of the WT level [47]. Because the
reason(s) for this is unknown, it is unclearwhether it is relevant
to interpreting the U40S results, but the possibility of mRNA
structural effects cannot be excluded.)
Prior in vitro studies showed greater processivity after an
initial restrictive event [14]. Though nothing is known of the
decoding of the 28 UGA codons in sea urchin selenoprotein P
mRNA, it is tempting to imagine that decoding of multiple
distal UGAs is processive without involvement of inde-
pendent SECIS interaction events. In mice with their Sepp1
mRNA lacking SECIS 1, consistent with ribosome specializ-
ation and its more effective mediation by SECIS 1, the
detectable plasma products mediated by SECIS 2 action are
almost all short form, likely due to termination at UGAs 2
or 3. To detect termination at UGA 1, we would have
had to use an upstream reporter and this could have
affected native upstream influences on the process. SECIS 2-
mediated ribosome specialization at UGA 2 and downstream
UGAs are at best ineffective. The difference between the
two SECIS elements could be due to any, or a combination,
of several reasons. One is potential differences in trans-
acting components associated with the two SECIS elements.
Another is different responses to factors at or close to,
UGA 1. Permissible mRNA folding could also be relevant.
Finally, SECIS 1 but not SECIS 2 may stably track with the
specialized ribosomes.
The finding of mostly truncated Sepp1 with the UGA 1
substitution mutation points to events at UGA 1 being impor-
tant for the ribosome specialization (figure 8). How does the
complex of the SECIS element involved and its associated
proteins, know where and how to contact the ribosome to
‘inform’ it that the first UGA is a selenocysteine codon and
not to mediate termination? It has been suggested that the
involvement of SECIS 2, but not SECIS 1, would be more
readily explicable if the former had features of their spatially
restrictive class of SECIS elements [57]. This may be one of
the relevant features, but others merit consideration. Our pre-
liminary data show no hints that a particular nascent peptide
signal interaction mediated ribosomal conformation change
may be relevant. If a small guide RNA has a role, perhaps
directing mRNA base modification, then it lurks undetected.
However, an exon junction complex might be very relevant to
the properties of the UGA 1 substitution mutant. The exon
junction protein eIF4a3, which shares homology to initiation
factor eIF4a1, is a selective negative regulator of selenoprotein
synthesis. During selenium deficiency, expression of eIF4a3 is
upregulated several fold and binds to a variable extent
to type 1 SECIS elements preventing, where tested, Sec inser-
tion [27,28]. Whether the hypermethylated cap structure of
selenoprotein mRNAs obviating eIF4E in initiation [76] is rel-
evant is unknown. eIF4E is normally loaded onto mRNA
with eIF4G that tethers the 43S ribosome complex and also
interacts with polyA binding protein. When eIF4G is itself
tethered to the 30 UTR of dicistronic mRNAs, it was found
to stimulate translation of the second ORF probably by
RNA looping [75]. Competition for its likely binding to
SECIS 2 (a type 1 element) by SBP2 is presumably facilitated
by weak binding of SBP2 to SECIS 2. This binding is likely
weaker than SECIS 1 [84], raising the potential for a tethering
role for linking the SECIS-associated complex to the vicinity of
UGA 1. However, while SBP2 is really important for Sepp1
expression [29,30], it is not essential and intriguingly plays a
major role in stabilizing Sepp1 mRNA [31]. Whether the
intron junction is relevant to this is unknown. As noted
above, the distance, 26 nt, from UGA 1 in pre-mRNA to a
downstream intron is highly conserved. After splicing, the
exon junction complex, which spans 20–24 nt 50 of the exon–
exon junction and contains eIF4a3, will be very close to the
first UGA. Could the potential tethering role of eIF4a3 at this
exon junction complex to SECIS 2 (possibly with involvement
of L30) mediate a coupling to a ribosome approaching UGA 1
with subsequent disruption of the eIF4a3 interaction being rel-
evant to loading of other factors, including EFsec, before the
UGA enters the ribosomal A site? While the presence of this
intron in a highly conserved position is likely relevant to
decoding of UGA 1, it is clearly not an absolute requirement
since constructs lacking this intron can still recode the first
UGA (although high levels of termination were also observed
and the constructs used had a reporter upstream rather than
the WT sequence arrangement [13]).
The conclusion that though SECIS 1 can suffice, the pres-
ence of SECIS 2 substantially enhances selenocysteine
specification at UGA 1 raises the question as to why SECIS
2 was selected. Is there some reason why SECIS 1 was not
selected to do the whole task? One possibility is that selection
for high processivity of SECIS 1 proved incompatible with a
counter selection for ribosome specialization at UGA 1 that
generated a certain level of short-form Sepp1. SECIS 2 may
have been the result.
4.3. Contrasting effects of features close to mRNA
30 ends on UGA redefinition
The major role of SECIS element(s) in the 30 UTR of eukary-
otic selenoprotein mRNAs in mediating the recoding of UGA
to specify selenocysteine contrasts with strong evidence for
features of the mRNA 30 ends being necessary for UGA,
and also UAA and UAG, to specify termination in ciliates
[87–89]. While in some ciliates occurrences of one or more
of these codons in internal regions of coding sequences is at
rsob.royalsocietypublishing.org
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least mostly avoided, in at least one species all 64 specify uni-
versal amino acids [87,88]. Relevance to the present work
comes from the emerging evidence that even in mammalian
cells natural termination has more components than pre-
viously appreciated, and includes some level of mRNA
30 end associated features [90].
4.4. Origin of selenoprotein P
The mammalian selenoprotein P gene (named Sepp1, or
also SelP, SelPa or Sepp1a) emerged early in vertebrates, by
duplication of a gene that encoded only its current N-terminal
domain. This shorter gene, named Sepp1b (or SelPb), is
still present in the genome of fishes, birds, reptiles and non-
placental mammals, while it was lost in placentals [91].
Sepp1b mRNA contains a single Sec-specifying UGA and a
single SECIS. It appears that extended vertebrate selenoprotein
P first appeared with a very Sec-rich C-terminus (more than 15
residues), and then the number of Sec residues was reduced in
many terrestrial tetrapods, including human and mouse, by
conversion to cysteine codons [42]. The gene duplication orig-
inating selenoprotein P has characteristics consistent with
its occurrence within one of the reported rounds of whole-
genomeduplications at the root of vertebrates [92]. Specifically,
we predict the duplication to have occurred in early Gnathos-
tomata ( jawed vertebrates) after the split with Cyclostomata
( jawless fishes). In fact, the genome of sea lamprey Petromyzon
marinus contains the parental Sepp1b gene, but not the seleno-
protein P gene (electronic supplementary material, figure S3b).
Sea urchin also possess a selenoprotein P gene with multiple
Sec residues [42]; however, this appears to have emerged in a
distinct phylogenetic event. Further research is currently
ongoing to better characterize the evolution of selenoprotein
P outside vertebrates. Throughout the duplication that gener-
ated Sepp1, intron positions were conserved, so that they are
shared by the extant vertebrate selenoprotein P and SelPb
genes. Thus, the intron next to UGA 1 is ancestral, already pre-
sent in the parental gene prior to duplication. It is possible, yet
speculative, that the presence of the intron at this position
played a role in the origin of the selenoprotein P gene itself.
We may imagine that in its early phases after duplication, the
new selenoprotein P gene could easily harbour multiple
UGAs, but probably contained a single SECIS. The hypoth-
esized tethering role of eIF4a3 could have helped deliver
the SECIS to the first UGA, which became increasingly distant
as the C-terminus tail grew bigger. Although likely inefficient,
such a system could have been enough to guarantee a
minimum amount of selenoprotein P with multiple Sec resi-
dues. Natural selection for this function would then have led
to the origin of SECIS 2, likely accompanied by changes to
the ancestral SECIS and establishment of the current system.
The appearance of extended vertebrate selenoprotein
P apparently coincided both with the emergence of its
C-terminus tail and of SECIS 2 in its mRNA; we could not
observe any species in intermediate states, e.g. a long selenopro-
tein P coding sequence with no SECIS 2, or a short coding
sequencewith both SECIS elements.We attempted to determine
the phylogenetic relationship of SECIS elements of selenoprotein
P and SelPa genes (see the electronic supplementary material,
S3). The SECIS elements analysed cluster in three distinct
groups: SECIS 1 of Sepp1, SECIS 2 of Sepp1 and SECIS of
Sepp1b. This is consistent with SECIS 1 and 2 being generated
by duplication of the SECIS in the ancestor Sepp1b. There is
no clear correspondence between the SECIS of Sepp1b and
any particular SECIS of selenoprotein P. The sequence identity
between the SECIS of Sepp1b and those of selenoprotein P
mRNAs are approximately the same. The SECIS in Sepp1b
genes is a type 2 element. Interestingly, both selenoprotein P
SECIS 1 and 2 are type 2 in fishes, while tetrapods mutated
SECIS 2 to type 1 (electronic supplementarymaterial, figure S3c).
The results presentedhere indicate that altering the functions
of SECIS 1 or SECIS 2 can alter the forms of Sepp1 protein syn-
thesized by the cell. Perhaps use of regulated SECIS inclusion
to modulate the relative and absolute abundance of Sepp1
protein isoforms has been a major driving force in development
of the remarkable recoding event involved.
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